Early research (Phase 1)Study completedNCT05897190
What this trial is testing
Evaluate the Safety and Immunogenicity of a SARS-CoV-2 mRNA Vaccine Booster
Who this might be right for
SARS-CoV-2
Argorna Pharmaceuticals Co., LTD 60
Showing 20 of 0 results